PRICE T ROWE ASSOCIATES INC /MD/ - CONSTELLATION PHARMCETICLS I ownership

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of CONSTELLATION PHARMCETICLS I
ValueSharesWeighting
Q2 2021$603,000
-95.2%
17,840
-96.7%
0.00%
-100.0%
Q1 2021$12,678,000
+71.1%
542,039
+110.7%
0.00%0.0%
Q4 2020$7,409,000
-22.7%
257,262
-45.6%
0.00%0.0%
Q3 2020$9,590,000
+16.5%
473,333
+72.7%
0.00%0.0%
Q2 2020$8,235,000
-50.4%
274,039
-48.1%
0.00%
-66.7%
Q1 2020$16,591,000
-12.7%
527,867
+30.8%
0.00%
+50.0%
Q4 2019$19,012,000
+950500.0%
403,575
+15.2%
0.00%
Q3 2019$2,000
-50.0%
350,225
+0.0%
0.00%
Q2 2019$4,000350,1930.00%
Other shareholders
CONSTELLATION PHARMCETICLS I shareholders Q3 2021
NameSharesValueWeighting ↓
Ponoi II Management, LLC 1,574,229$45,338,00033.03%
Ponoi Management, LLC 1,880,623$54,162,00030.99%
VR Adviser, LLC 4,016,873$115,686,00017.01%
Column Group LLC 2,626,631$75,647,0006.86%
COMMODORE CAPITAL LP 423,708$12,203,0006.64%
GREAT POINT PARTNERS LLC 1,024,800$29,514,0004.79%
Venrock Management V, LLC 1,557,276$44,850,0004.23%
Ghost Tree Capital, LLC 625,000$18,000,0004.01%
Euclidean Capital LLC 554,325$15,965,0003.38%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 737,406$21,237,0003.07%
View complete list of CONSTELLATION PHARMCETICLS I shareholders